Research Grants 800 show all


$44.6M
2016

$40.2M
2017

$42M
2018

$43.1M
2019

$28.4M
2020

Patents 31show all

  • 14
    A61K - Preparations for medical, dental, or toilet purposes
  • 13
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 5
    C07K - Peptides
  • 5
    C12N - Microorganisms or enzymes
  • 4
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 1
    A01K - Animal husbandry
  • 1
    A61B - Diagnosis
  • 1
    A61N - Electrotherapy

Publications 890 show all

  • 90
    CD4-Positive T-Lymphocytes/immunology
  • 59
    Diabetes Mellitus, Type 1/immunology
  • 53
    T-Lymphocytes, Regulatory/immunology
  • 40
    T-Lymphocytes/immunology
  • 37
    Epitopes, T-Lymphocyte/immunology
  • 25
    T-Lymphocyte Subsets/immunology
  • 24
    Diabetes Mellitus, Type 1/genetics
  • 17
    Diabetes Mellitus, Type 1/drug therapy
  • 16
    Allergens/immunology
  • 16
    Cytokines/immunology

Clinical Trials 91show all

33Phase 213N/A13Phase 38Phase 110Other

Contact Information

Virginia Mason. 1201 Ninth Avenue
Seattle, WA 98101-2795
United States